3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

3.2 By 2030, end preventable deaths of newborns and under-five children

  • GRI Indicators: former FP4 (Food Processing Sector Disclosure)

3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria, and neglected tropical diseases and combat hepatitis, water-borne diseases, and other communicable diseases

3.4 By 2030, reduce by one-third pre-mature mortality from non-communicable diseases (NCDs) through prevention and treatment, and promote mental health and wellbeing

3.5 Strengthen prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

  • GRI Indicators: M4, M5

3.6 By 2020, halve global deaths and injuries from road traffic accidents

3.7 By 2030, ensure universal access to sexual and reproductive health care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programs

  • Poverty Footprint Indicators: PF-14.7 iii)

3.8 Achieve universal health coverage (UHC), including financial risk protection, access to quality essential health care services, and access to safe, effective, quality, and affordable essential medicines and vaccines for all

3.9 By 2030 substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water, and soil pollution and contamination


3.a. Strengthen implementation of the Framework Convention on Tobacco Control in all countries as appropriate

3.b. Support research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration which affirms the right of developing countries to use to the full the provisions in the TRIPS agreement regarding flexibilities to protect public health and, in particular, provide access to medicines for all

  • Access to Medicine Indicators: B.III.4, C.III.1, E.I.1, E.II.1, E.III.2

3.c. Increase substantially health financing and the recruitment, development and training and retention of the health workforce in developing countries, especially in LDCs and SIDS

  • Access to Medicine Indicators: G.I.3, G.III.3, G.III.4

3.d. Strengthen the capacity of all countries, particularly developing countries, for early warning, risk reduction, and management of national and global health risks

Metric Type
Value Type
Research Policy
1045 3239
1010 3012
439 935
673 1516
708 1836
737 1872
725 1932
670 1666
620 1292
901 2197
128 298
672 1556
636 1421
569 1463
700 1522
744 1896
650 1402
645 1452
737 1630